☰

282 Pharmaceuticals Reseach Report Available

AI-Based Clinical Trial Solution Providers Market Size, Share & Trends Analysis Report By Target Therapeutics (Cardiovascular Disorders, CNS Disorders, Infectious Disorders, Metabolic Disorders, Oncological Disorders, and Other Disorders), By Trial Phase, By End Users, Region And Segment Forecasts, 2023-2031.

Report ID : 1082 | Published : 2023-07-07 | Pages: 180 | Format:

The AI-Based Clinical Trial Solution Providers Market Size is valued at 1560.0 Million in 2022 and is predicted to reach 8926.2 Million by the year 2031 at a 21.5 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Rituximab Biosimilar Market Size, Share & Trends Analysis Report By Application, By Route of Administration, By Molecule Type, By Distribution Channel Region And Segment Forecasts, 2023-2031.

Report ID : 1081 | Published : 2023-07-05 | Pages: 180 | Format: PDF/EXCEL

The Rituximab Biosimilar Market is expected to grow at a 12.0 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Trastuzumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Ogivri, Herzuma, Ontruzant, Trazimera, Other Pipeline Products), By Indication, By Route of Administration, By Molecule Type, Region And Segment Forecasts, 2023-2031.

Report ID : 1080 | Published : 2023-07-18 | Pages: 180 | Format: PDF/EXCEL

The Trastuzumab Biosimilar Market is expected to grow at a 25.0 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 4456
View Sample PDF

Anti-Nerve Growth Factor Market Outlook, Clinical Trial/Pipeline Analysis, Competitive Landscape, and Market Forecast Report – 2023 To 2031

Report ID : 1079 | Published : 2023-07-04 | Pages: | Format: PDF/EXCEL

Global Anti-Nerve Growth Factor Market is a tumor tissue produced growth factor that promotes the growth and differentiation of sympathetic and sensory ganglia. It is the first growth factor to be identified. An elevated level of nerve growth factor ... Read More >>
$ 3786
View Sample PDF

Cancer Biosimilars Market Size, Share & Trends Analysis Report By Type (Lung Cancer, Breast cancer, Ovarian cancer, Prostate cancer, Lymphoma, Others), By Distribution Channel, By Drug Class, By Route of Administration, Region And Segment Forecasts, 2023-2031.

Report ID : 1078 | Published : 2023-07-04 | Pages: 180 | Format: PDF/EXCEL

The Cancer Biosimilars Market is expected to grow at a 20.0 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Filgrastim Biosimilars Market Size, Share & Trends Analysis Report By Application (Febrile Neutropenia, Genital Neutropenia, Idiopathic Neutropenia, and Others), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, and Retail Pharmacy), Region And Segment Forecasts, 2023-2031.

Report ID : 1076 | Published : 2023-07-26 | Pages: 175 | Format: PDF/EXCEL

The Filgrastim Biosimilars Market Size is valued at 965.07 Million in 2022 and is predicted to reach 1945.12 Million by the year 2031 at an 8.2 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Global Cancer Immunomodulators Pipeline Market

Report ID : 1074 | Published : 2022-08-16 | Pages: 140 | Format: PDF/EXCEL

Global Cancer Immunomodulators Pipeline Market Prevention of progression and proliferation of infectious diseases in the body has always been the point of discussion, which has developed a throng of techniques to alter these effects of the immune sys ... Read More >>
$ 3786
View Sample PDF

Bevacizumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Avastin, Mvasi, Zirabev, Aybintio, Other Clinical Trial Products), By Application, By Distribution Channel, Region And Segment Forecasts, 2023-2031.

Report ID : 1073 | Published : 2023-07-26 | Pages: 170 | Format: PDF/EXCEL

The Bevacizumab Biosimilar Market is expected to grow at an 18.40 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

TNF Biosimilars Market Size, Share & Trends Analysis Report By Drug (Adalimumab Biosimilar, Infliximab Biosimilar, Certolizumab Biosimilar, Etanercept Biosimilar, and Golimumab Biosimilar), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy), Region And Segment Forecasts, 2023-2031.

Report ID : 1072 | Published : 2023-07-26 | Pages: 180 | Format: PDF/EXCEL

The TNF Biosimilars Market is expected to grow at a 14.90 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Clinical Trial Services Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III, and Others), By Therapy Area (Oncology, Neurological Disorder, Metabolic Disease, Cardiovascular, Rare Diseases, Infectious Diseases, and Others), Region And Segment Forecasts, 2023-2031.

Report ID : 1071 | Published : 2023-06-17 | Pages: 180 | Format: PDF/EXCEL

The Clinical Trial Services Market is expected to grow at an 8.0 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Deep Vein Thrombosis Market Size, Share & Trends Analysis Report By Treatment (Clot Busters, Blood Thinners, Inferior Vena Cava Filters, Compression Stockings, Others), By Distribution Channel, Region And Segment Forecasts, 2023-2031.

Report ID : 1070 | Published : 2023-07-26 | Pages: 180 | Format: PDF/EXCEL

The Deep Vein Thrombosis Market Size is valued at 958.11 Million in 2022 and is predicted to reach 1343.86 Million by the year 2031 at a 4.0 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Breast Cancer Market Size, Share & Trends Analysis Report By Treatment (Chemotherapy, Hormonal Therapy, Targeted Therapy, and Surgery), Region And Segment Forecasts, 2023-2031.

Report ID : 1069 | Published : 2023-06-17 | Pages: 140 | Format: PDF/EXCEL

The Breast Cancer Market is expected to grow at an 8.5 % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Etanercept Biosimilar Market Size, Share & Trends Analysis Report By Applications (Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, And Ankylosing Spondylitis), Distribution Channel, Region And Segment Forecasts, 2023-2031.

Report ID : 1068 | Published : 2023-07-12 | Pages: 180 | Format: PDF/EXCEL

The Etanercept Biosimilar Market Size is valued at XX Million in 2022 and is predicted to reach XX Million by the year 2031 at an XX % CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Ovarian Cancer Market Size, Share & Trends Analysis Report By Treatment (Chemotherapy, Hormonal Therapy, Targeted Therapy, and Surgery), Region And Segment Forecasts, 2023-2031.

Report ID : 1067 | Published : 2023-06-17 | Pages: 180 | Format: PDF/EXCEL

The Ovarian Cancer Market is expected to grow at a 10.0% CAGR during the forecast period for 2023-2031. ... Read More >>
$ 3786
View Sample PDF

Global Cancer Angiogenesis Pipeline Market

Report ID : 1066 | Published : 2022-08-16 | Pages: 140 | Format: PDF/EXCEL

Global Cancer Angiogenesis Pipeline Market number of new cancer cases is predicted to rise by 54% within the next two decades. In economically developing countries, adoption of western lifestyles, such as smoking, poor diet, physical inactivity. ... Read More >>
$ 3786
View Sample PDF
Categories
Press Release

Global Animal Microbiome Market: Research and Development Investment expected to enhance product dev...

The increase in obese population and rise in prevelance of cancer to drive the growth of Antibody Dr...

Growing Demand for Hydrogen Peroxide Plasma Sterilization across the Healthcare is Expected to Boost...

Implantable Neurostimulators Market: Increasing Incidence of Various Chronic Disorders is Augmenting...

Growing Inclination towards Personalized Solutions Globally is one of the Key Drivers Expected to Ne...

Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.

Category
Quick Links
Office Address